New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Collagen a key player in breast cancer metastasis

Collagen a key player in breast cancer metastasis

byGarvan Institute of Medical ResearchCollagen fibers running through a cancer tumor, created using a multiphoton microscope. The coloring is a visual representation of how collagen fibers are o
Oncology December 18,2023
Collagen a key player in breast cancer metastasis

Collagen a key player in breast cancer metastasis

byGarvan Institute of Medical ResearchCollagen fibers running through a cancer tumor, created using a multiphoton microscope. The coloring is a visual representation of how collagen fibers are o
Oncology December 18,2023
Hormonal breast cancer treatment reduces long-term risk of recurrence

Hormonal breast cancer treatment reduces long-term risk of recurrence

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of
Oncology December 18,2023
Hormonal breast cancer treatment reduces long-term risk of recurrence

Hormonal breast cancer treatment reduces long-term risk of recurrence

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of
Oncology December 18,2023
Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can reduce trea
Oncology December 18,2023
Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can reduce trea
Oncology December 18,2023
Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainAn online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people
Oncology December 18,2023
Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainAn online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people
Oncology December 18,2023
Skin cancer cells harness nerve cell gene to drill through and invade new tissues

Skin cancer cells harness nerve cell gene to drill through and invade new tissues

byInstitute of Cancer ResearchMelanoma cell growing into a soft hydrogel. Credit: Professor Chris BakalMelanoma skin cancer cells harness a gene usually used by growing nerves to escape from the
Oncology December 18,2023
Skin cancer cells harness nerve cell gene to drill through and invade new tissues

Skin cancer cells harness nerve cell gene to drill through and invade new tissues

byInstitute of Cancer ResearchMelanoma cell growing into a soft hydrogel. Credit: Professor Chris BakalMelanoma skin cancer cells harness a gene usually used by growing nerves to escape from the
Oncology December 18,2023
Researchers identify an Achilles' heel in neuroblastoma

Researchers identify an Achilles' heel in neuroblastoma

by Molly Chiu,Baylor College of MedicineThe image shows magnified neuroblastoma cells. Credit: Baylor College of MedicineNeuroblastoma, a childhood cancer that develops from neural cells on the
Oncology December 18,2023
Researchers identify an Achilles' heel in neuroblastoma

Researchers identify an Achilles' heel in neuroblastoma

by Molly Chiu,Baylor College of MedicineThe image shows magnified neuroblastoma cells. Credit: Baylor College of MedicineNeuroblastoma, a childhood cancer that develops from neural cells on the
Oncology December 18,2023
Potential new treatment for angioimmunoblastic T-cell lymphoma

Potential new treatment for angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: AI-generated imageA type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from
Oncology December 18,2023
Potential new treatment for angioimmunoblastic T-cell lymphoma

Potential new treatment for angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: AI-generated imageA type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from
Oncology December 18,2023
International study designed to identify melanoma patients with high-risk disease

International study designed to identify melanoma patients with high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteMelanoma. Credit: Wikimedia Commons/National Cancer InstituteThe use of additional adjuvant therapy beyond initial treatment has greatly im
Oncology December 18,2023
International study designed to identify melanoma patients with high-risk disease

International study designed to identify melanoma patients with high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteMelanoma. Credit: Wikimedia Commons/National Cancer InstituteThe use of additional adjuvant therapy beyond initial treatment has greatly im
Oncology December 18,2023
Mayo Clinic Minute: Learning the 'ABCDEs' of melanoma

Mayo Clinic Minute: Learning the 'ABCDEs' of melanoma

by Alex OsiadaczMelanoma. Credit: Wikimedia Commons/National Cancer InstituteMelanoma is a type of skin cancer that develops in cells that produce your skin's pigment. Regular skin checks can help
Oncology December 18,2023
Mayo Clinic Minute: Learning the 'ABCDEs' of melanoma

Mayo Clinic Minute: Learning the 'ABCDEs' of melanoma

by Alex OsiadaczMelanoma. Credit: Wikimedia Commons/National Cancer InstituteMelanoma is a type of skin cancer that develops in cells that produce your skin's pigment. Regular skin checks can help
Oncology December 18,2023
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainGenetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, c
Oncology December 18,2023
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainGenetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, c
Oncology December 18,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com